Cognoa - About the company
Cognoa is a series B company based in Palo Alto (United States), founded in 2013 by Dennis Wall. It operates as a Developer of AI-powered diagnostic tools for early childhood developmental disorders. Cognoa has raised $20M in funding from 5Y Capital. The company has 10 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like Aifred Health, GaitIQ and Medibio.
Company Details
Developer of AI-powered diagnostic tools for early childhood developmental disorders. It offers a digital solution for the rapid and equitable diagnosis of autism in young children. This technology aims to overcome geographical barriers to specialized care and reduce diagnostic delays, enabling earlier interventions. The solution utilizes objective, data-driven methods to mitigate biases in diagnosis and improve access to timely treatment. It provides clinicians with a faster path to determining next steps for children, regardless of diagnosis.
- Website
- cognoa.com
- Registered Address
- 2185 PARK BLVD,PALO ALTO,CA,94306,0
Key Metrics
Founded Year
2013
Location
Palo Alto, United States
Stage
Series B
Total Funding
$20M in 2 rounds
Latest Funding Round
Investors
Ranked
1st among 10 active competitors
Employee Count
41 as on Aug 31, 2026
Similar Companies
Legal entities associated with Cognoa
Cognoa is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Cognoa, Inc. CIN: 32082409494 , United States, Active | - | 37 (As on Dec 31, 2023) | - |
Sign up to download Cognoa's company profile
Cognoa's funding and investors
Cognoa has raised a total funding of $20M over 2 rounds. Its first funding round was on 2014. Its latest funding round was a Series B round on Mar 27, 2017 for $*****. 1 investor participated in its latest round. Cognoa has 2 institutional investors.
Here is the list of recent funding rounds of Cognoa:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 27, 2017 | 8331556 | Series B | 7837144 | 7779290 | 9767645 | 9295014 |
2014 | 6785 | Series A | 9515 | 9064 | 9671 |
View details of Cognoa's funding rounds and investors
Cognoa's founders and board of directors
Founder? Claim ProfileThe founders of Cognoa is Dennis Wall.
Here are the details of Cognoa's key team members:
- Dennis Wall: Founder of Cognoa.
View details of Cognoa's Founder profiles and Board Members
Cognoa's employee count trend
Cognoa has 41 employees as of Aug 26. Here is Cognoa's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cognoa's Competitors and alternates
Top competitors of Cognoa include Aifred Health, GaitIQ and Medibio. Here is the list of Top 10 competitors of Cognoa, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cognoa 2013, Palo Alto (United States), Series B | Developer of AI-powered diagnostic tools for early childhood developmental disorders | $20M | 57/100 | |
2nd | Aifred Health 2016, Montreal (Canada), Seed | AI-driven clinical decision support tools for personalized treatment in mental health | $4.37M | 43/100 | |
3rd | GaitIQ 2017, San Antonio (United States), Funding Raised | Provider of AI-based neurological disease detection software | - | 32/100 | |
4th | Provider of data-driven tools for the early detection and management of mental health disorders | - | 30/100 | ||
5th | DigiCARE Realized 2022, United States, Unfunded | AI-powered tools for early detection and diagnosis of brain diseases | - | - | 25/100 |
6th | EpiFinder 2014, Phoenix (United States), Seed | Software solution for diagnosis of epilepsy syndromes at the point of care. | $438K | - | 25/100 |
7th | COMT 2015, Aurora (United States), Unfunded | Provider of neuromusculoskeletal diagnosis management systems | - | - | 24/100 |
8th | Prodromic 2024, Codsall (United Kingdom), Unfunded | Developer of AI solutions for early prediction in neurological conditions | - | - | 24/100 |
9th | Neuromap 2024, London (United Kingdom), Unfunded | AI-powered brain analysis and personalized healthcare solutions provider | - | - | 16/100 |
10th | Co-counselor 2024, Los Angeles (United States), Unfunded | AI-driven platform focused on automating and streamlining the intake process for addiction treatment | - | - | 16/100 |
Looking for more details on Cognoa's competitors? Click here to see the top ones
Cognoa's Investments and acquisitions
Cognoa has made no investments or acquisitions yet.
Reports related to Cognoa
Here is the latest report on Cognoa's sector:
News related to Cognoa
Media has covered Cognoa for a total of 2 events in the last 1 year, 1 of them has been about partnerships.
•
Collaboration Connects Early Autism Diagnosis with High-Quality, Outcomes-Driven Care Amid Industry-Wide Access IssuesPR Newswire•Apr 21, 2026•Catalight, Cognoa
•
Elevation Capital leads $10.2m round for India’s GreyLabs AITech in Asia•Oct 06, 2025•GreyLabs, Elevation Capital, Cognoa, Exotel and 1 other
•
Cognoa Launches First State Medicaid Program to Cover AI-Powered Autism DiagnosticHIT Consultant•Sep 26, 2024•Cognoa
•
•
ECHO Autism Communities Collaborate with Cognoa to Study Real-World Application of Canvas DxMedical Device News•Jun 01, 2022•Cognoa, ECHO Autism
•
•
•
Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal StudyGlobeNewswire•Sep 23, 2020•Cognoa
•
Cognoa Appoints Industry Leader David Happel as New Chief Executive OfficerGlobeNewswire•Mar 24, 2020•Cognoa, Chrono Therapeutics
•
Are you a Founder ?
FAQs about Cognoa
Explore our recently published companies
- Frukt AS - Norway based, Unfunded company
- Ojha Sir Gyanshala - Unfunded company
- Ozeku - Unfunded company
- Mainmeditech - China based, 2020 founded, Unfunded company
- MOBYLIZ - France based, 2020 founded, Unfunded company
- Dave Carmack - Unfunded company